International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 1 : 3251-3256
Research Article
Role of Cytological and Radiological Correlation in Mass Lesions of Lung in A Tertiary Care Centre of Hadoti Region
 ,
 ,
Received
Dec. 23, 2025
Accepted
Jan. 6, 2026
Published
Jan. 25, 2026
Abstract

Introduction – Lung lesions include a variety of benign and malignant lesions. According to WHO, 2022 data, lung carcinoma is the most common cancer worldwide and is the most common cause of cancer related deaths. This study was carried out to know the cyto-radiological correlation in mass lesions of lung.

Aims- This study was conducted to know the pathological spectrum of lung lesions and to correlate the radiological findings with USG /CT guided FNAC findings.

Methods – This study was carried out on 100 patients in the Department of Pathology at Government Medical College, Kota for a period of 15 months from January 2023 to March 2024. Patients with suspected lung lesions, were the study subjects. USG/ CT guided FNAC was carried out, examined, and compared with radiological diagnoses.

Results - Adequate sampling material was obtained in 93 patients out of 100 patients. The Cytoradiological correlation was found to be 89.24%. Based on cytology, the most common malignant lesion was Adenocarcinoma (31.18%) followed by Squamous cell carcinoma (29.03%), Small cell carcinoma (12.90%), Poorly differentiated carcinoma (4.30%). 5.37% cases were suspicious for malignancy and 8.60% cases were diagnosed as non-specific inflammatory pathology.

Conclusion – Guided FNAC helps in early detection and diagnosis of lung lesions. Further FNAC in conjunction with radiological diagnosis provides an better accurate diagnosis.

Keywords
INTRODUCTION

According to WHO, 2022 survey, lung carcinoma is the most common cancer (12.4%) worldwide and is the most common cause of cancer related deaths (18.7%). Despite tremendous efforts to treat this cancer, the overall 5-year survival for all stages is dismally low at 15%.1 About 85–90% of patients with lung cancer have had direct exposure to tobacco. The strongest associations are with small cell and squamous cell carcinoma.2 Although clinical data, location, and radiological findings can narrow down diagnostic possibilities, a definitive diagnosis confirming lung cancer by microscopic examination is indicated before therapy.3 In clinically suspected cases of lung cancer, if histologic confirmation is not there, cytologic confirmation is suffice4. Further a Cytologic- Radiologic correlation in lung lesions provide better accurate diagnosis and helps in proper management of the patient.

 

The purpose of this study to find out pathological spectrum of lung lesions and to correlate cytological findings with the radiological findings.

 

AIMS AND OBJECTIVES –

The study was conducted to find out pathological spectrum of lung lesions based on cytomorphological features and to correlate cytological diagnosis with the radiological diagnosis.

 

 

 

MATERIALS AND METHODS -

This is a cross-sectional study, carried out in Department of Pathology at Government Medical College, Kota for a period of 15 months from January 2023 to March 2024. Total 100 patients were included in the study.

 

Inclusion criteria:

Patients of all age groups who were advised guided FNAC for lung lesions.

 

Exclusion criteria:

  1. Patient with suspected bleeding diathesis and on anticoagulant medication.
  2. Patient who are unconscious or who cough intractably.
  3. Cases whose radiology was not available.

The procedure was explained to the patient before aspiration and written consent was taken.

 

The sample was taken under USG or CT scan guidance by 22 gauge, 90 mm disposable lumbar puncture needle. The aspirate was blown onto clean glass slides. Smears were made by applying gentle pressure with another slide and then air dried. Air dried smears were fixed with methanol for 15-20 minutes. Staining was done with giemsa stain. The slides were examined for cytomorphological features and cytological diagnosis was correlated with the radiological diagnosis.

 

RESULT –

Total 100 patients were included in this study. Most of the cases were in the age group 61-70 years with 52 patients (52%) followed by age group 51-60 years with 26 patients (26%) (Table 1). There were 83 male patients and 17 female patients with male to female ratio 4.88:1 (Graph 1).

 

Table 1: Age distribution of lung lesions

Age Group

No. of patients

Percentage

0-40 years

1

1%

41-50 years

11

11%

51-60 years

26

26%

61-70 years

52

52%

71-80 years

10

10%

 

 

Adequate material for reporting cytology, was obtained in 93 out of 100 patients. The material was inadequate in 7 cases on repeated aspirations. These cases were omitted for further calculations.

  • The radiological and cytological diagnoses were concordant in 83 cases out of 93 cases (Table 2).
  • The cytoradiological correlation was found to be 89.24% (Table 3).
  • Discrepancy was noted in 10 (10.76%) out of 93 cases between radiological and Cytological diagnosis.

The most common lesion found on cytology was adenocarcinoma 29 cases (31.18%). All these 29 cases were diagnosed as malignant on radiology. The second most common lesion on cytology was squamous cell carcinoma 27 cases (29.03%).

 

Among these 27 cases, 26 cases were diagnosed as malignant on radiology and one case was diagnosed as benign etiology.

There were 12 cases (12.90%) diagnosed as small cell carcinoma and 4 cases (4.30%) diagnosed as poorly differentiated carcinoma on cytology. All these 16 cases were given malignant on radiology.

 

There were 5 cases (5.37%) with suspicion for malignancy. These cases were given as malignant on radiology.

  • 8 cases (8.60%) were diagnosed as non specific inflammatory pathology on cytology. Out of these 8 cases, 3 cases were given benign and 4 cases were given malignant on radiology.
  • 6 cases (6.45%) were diagnosed as tubercular pathology on cytology. Out of these 6 cases only 2 cases were concordant on radiology and 4 cases were given malignant.
  • 1 case (1.07%) was diagnosed as benign cystic lesion on cytology and
  • 1 case as fungal infection. These cases were concordant on radiology.

 

There were 83 concordant cases on radiology and cytology while 10 cases were discordant. The cytoradiological correlation was 89.24%.

 

Table 2: Cytological and radiological correlation of lung lesions

Cytological diagnosis

Cases numb ers

Concord ant

Radiologi cal

diagnosis of concorda nt cases

Discord ant

Radiologi cal

diagnosis of

discorda nt cases

Adenocarcin oma

29

 

29(100%

)

Neoplasti c etiology

0

-

Squamous cell carcinoma

27

26(96.29

%)

Neoplasti c etiology

1(3.70%)

Progressi ve

massive fibrosis

Small   cell carcinoma

12

12(100%

)

Neoplasti c etiology

0

-

Poorly

differentiated carcinoma

4

4(100%)

Neoplasti c etiology

0

-

Suspicious for malignancy

5

5(100%)

Neoplasti c etiology

0

-

Non-specific inflammatory pathology

8

3(37.5%)

Infective etiology

5(62.5%)

Neoplasti c etiology

Tubercular pathology

6

2(33.33

%)

Tubercul ar etiology

4(66.66

%)

Neoplasti c etiology

Benign cystic lesion

1

1(100%)

Infective etiology

0

-

Fungal pathology

1

1(100%)

Fungal etiology

0

-

Total number

93

83(89.24

%)

-

10(10.75

%)

-

 

Table 3: Rate of concordance in cytological and radiological diagnosis

 

Similar

diagnosis                     on

cytology                  and radiology

Dissimilar

diagnosis                     on

cytology                  and radiology

Malignant lesion

71

1

Benign lesion

7

9

Suspicious for malignancy

5

0

No. of patients

83

10

Percentage

89.24%

10.75%

 

Among 72 cytological malignant lesions, 71 cases were given as malignant on radiology and one case was given benign.

5 case with cytological suspicion for malignancy, were also given as suspicious for malignancy on radiology.

  • Among 16 cytological benign lesions, 7 cases were given benign and 9 cases were given as malignant on radiology.
  • Discrepancy was noted in 10 out of 93 cases. This discrepancy was more for benign lesion than the malignant lesions. Among malignant lesions, discrepancy was noted only in one case while among benign lesions, discrepancy was noted in 9 cases.
  • One case reported as progressive Massive fibrosis on radiology, was diagnosed as squamous cell carcinoma on FNAC.
  • 4 cases of tubercular pathology were misdiagnosed as malignant on radiology. These patients were recovered after anti-tubercular treatment. 5 cases reported as malignant on radiology, were diagnosed as non-specific inflammatory pathology on FNAC.

 

Figure-1: Cytomorphological features of lung lesions

 

Figure-1: (A) Pleomorphic cells in squamous cell carcinoma with blue cytoplasm and hyperchromatic nuclei [MGG, 100x]. (B) Irregular solid cohesive sheet in squamous cell carcinoma [MGG, 100x]. (C) Sheet of cells with moderate to abundant amount of cytoplasm and eccentric round nuclei in adenocarcinoma [MGG, 200x].

 

Figure-2: Cytomorphological features of lung lesions

 

Figure-2: (D) Sheet of cells with nuclear moulding and fine granular chromatin in small cell carcinoma [MGG, 400x]. (E) Poorly differentiated atypical cells in poorly differentiated carcinoma [MGG, 400x]. (F) Epithelioid cells forming granuloma [MGG, 400x].

 

Cytological and radiological correlation provides a better accurate diagnosis of lung lesions and helps in better management of the patients.

 

DISCUSSION –

According to WHO, 2022 survey, lung carcinoma is the most common cancer worldwide and is the leading cause of cancer related deaths. The present study was conducted to correlate cytological and radiological in diagnosis of lung lesions for better accurate diagnosis and management.

 

This study showed peak age group of presentation of lung lesion was 51-60 years with average age of presentation 55.5 years. Similar average age of presentation was found in the study done by Ahmed Z et al. (2018)5 and Chakrabarti PR et al. (2020)6.

 

The male preponderance was consistent with the studies done by Baby J et al. (2014)7 And Ahmed Z et al. (2018)5, Chakrabarti PR et al. (2020)6.

 

The cytoradiological correlation in the present study was found to be 89.24%. This was similar to studies done by Piplani S et al. (2014)8 (Table 4). This was slightly lower as compared to other studies done by Biswas P et al. (2016)9, Gadodiya K et al. (2019)10 and Chakrabarti PR et al. (2020)6. It may be because, in the present study, a greater number of inflammatory cases were reported as malignant on radiology.

 

Table 4: Comparison of cytoradiological Correlation

 

Cytoradiological correlation

Piplani S et al. (2014)8

89.2%

Biswas P et al. (2016)9

92.6%

 

 

Gadodiya K et al. (2019)10

91.89%

Chakrabarti PR et al. (2020)6

90.40%

Present study

89.24%

 

Discrepancy was noted in 10 out of 93 cases. This discrepancy was more for benign lesions than the malignant lesions.

There was 100% cytoradiological concordance in cases reported as adenocarcinoma on cytology. One case reported as progressive massive fibrosis on radiology turned out to be squamous cell carcinoma on cytology.

 

Five cases of neoplastic etiology on radiology, turned out to be non- specific inflammatory pathology on cytology. These patients improved after conservative management.

 

Four cases of neoplastic etiology on radiology, turned out to be tubercular pathology on cytology. All these patients improved after anti-tubercular treatment.

 

Although histopathological diagnosis is gold standard for diagnosis of lung lesions, guided FNAC in conjunction with radiology provides a great help in early diagnosis and management of the patient.

 

CONCLUSION

In the present study, cytopathological diagnoses of various lung lesions were correlated with radiological diagnoses. The cytoradiological correlation found to be 89.24%. Correlation among diagnostic modalities provides a better diagnostic impression and helps in better management of the patient. Further guided FNAC is a safe and minimally invasive procedure for early diagnosis and subcategorization of lung lesions.

 

LIMITAIONS - No histopathological correlation was available in this study.

 

BIBLIOGRAPHY –

  1. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111(6):1710-1717.
  2. lribarren C, Tekawa IS, Sidney S and Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med. 1999;340(23):1773-1780.
  3. Saha A, Kumar K and Choudhuri MK. Computed tomography- guided fine needle aspiration cytology of thoracic mass lesions: A study of 57 cases. J Cytol. 2009;26(2):55-59.
  4. Vyas JJ, Desai PB and Rao ND. Relative accuracy of diagnostic method in bronchogenic carcinoma. J Surg Oncol. 1982;21(1):45-48.
  5. Ahmed Z, Israt T, Raza AM, Hossain SA, Shahidullah M. CT guided FNAC of lung mass- A retrospective study of disease spectrum. J Histopathol Cytopathol. 2018;2:109-13.
  6. Chakrabarti PR, Chakraborty K, Kukreja P. Role of image-guided fine needle aspiration cytology of lung lesions in diagnosis and primary care of patients: Experience in a government Medical College of Eastern India. J Family Med Prim Care. 2020 Jun 30;9(6):2785-88.
  7. Baby J, George P. Computed tomography guided fine needle aspiration cytology of thoracic lesions: A retrospective analysis of 114 cases. IOSR Journal of Dental and Medical Sciences. 2014 Jan;13(1):47-52.
  8. Piplani S, Mannan R, Lalit M, Manjari M, Bhasin TS, Bawa J. CytologicRadiologic Correlation Using Transthoracic CT- Guided FNA for Lung and Mediastinal Masses: Our Experience. Analytical cellular pathology (Amsterdam). 2014;2014:343461.
  9. Biswas P, Datta A, De A, SinhaLK. Pulmonary Mass Lesions: CT Scan Diagnostic-Impressions and FNAC Diagnoses - A Correlative Study. Int J Med Res Rev [Internet]. 2016 Jun.30;4(6):1052-6.
  10. Gadodiya K, Patil RN, Kumbhalkar D, Raut WK. Computed tomography Guided fine needle aspiration cytology of lung and mediastinal Lesions. International Journal of Contemporary Medical Research. 2019;6(2):B7-12.
Recommended Articles
Research Article Open Access
Evaluating Medication Safety in the Elderly: Prevalence of Potentially Inappropriate Prescribing and Clinically Significant Drug-Drug Interactions.
2026, Volume-7, Issue 3 : 288-298
Original Article Open Access
PREDICTIVE UTILITY OF SYSTEMIC INFLAMMATORY MARKERS IN PATIENTS WITH CARDIAC AND CEREBROVASCULAR EVENTS AT A TERTIARY CARE HOSPITAL
2026, Volume-7, Issue 3 : 267-273
DOI: 10.5281/zenodo.20128026
Original Article Open Access
CLINICAL PROFILE, ETIOLOGY, AND OUTCOMES OF ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE FEBRILE ILLNESS: A HOSPITAL-BASED CROSS-SECTIONAL STUDY
2026, Volume-7, Issue 3 : 281-287
DOI: 10.5281/zenodo.20128226
Original Article Open Access
BARRIERS TO CATARACT SURGERY UPTAKE AMONG PATIENTS WITH OPERABLE CATARACT ATTENDING A TERTIARY CARE CENTRE IN SOUTH RAJASTHAN: A CROSS-SECTIONAL STUDY
2026, Volume-7, Issue 3 : 274-280
DOI: 10.5281/zenodo.20128138
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 1
Citations
3 Views
5 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved